MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- A1947 MEK162 (ARRY-162, ARRY-438162)Target: MEKSummary: MEK1/2 inhibitor,potent and selective
- A1952 NSC23766 trihydrochlorideSummary: Selective inhibitor of Rac1-GEF interaction.
- A1413 CEP-32496Summary: BRAF(V600E)inhibitor,highly potent
- A8304 FR 180204Target: ERKSummary: ERK inhibitor
- A8308 PH-7978041 CitationSummary: P38 MAP kinase inhibitor, potent and selective
- A8313 RAF265Target: Raf|VEGFRSummary: Multiple intracellular kinases inhibitor
- A8371 AZ 628Summary: Raf kinases,potent and ATP-competitive
- A8374 AZD8330Target: MEKSummary: MEK 1/2 inhibitor
- A8435 FurosemideTarget: Na /K /Cl- Symporters (NKCCs)|GABAA ReceptorsSummary: GABAA receptors antagonist
- A8545 ZM336372Summary: C-Raf inhibitor, potent and selective